428 related articles for article (PubMed ID: 37446262)
1. From the Bush to the Brain: Preclinical Stages of Ethnobotanical Anti-Inflammatory and Neuroprotective Drug Discovery-An Australian Example.
Kumar P; Mathew S; Gamage R; Bodkin F; Doyle K; Rossetti I; Wagnon I; Zhou X; Raju R; Gyengesi E; Münch G
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446262
[TBL] [Abstract][Full Text] [Related]
2. Potential anti-neuroinflammatory compounds from Australian plants - A review.
Singh A; Raju R; Münch G
Neurochem Int; 2021 Jan; 142():104897. PubMed ID: 33186611
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of nonsteroidal anti-inflammatory drugs on neurodegenerative diseases.
Asanuma M; Miyazaki I; Ogawa N
Curr Pharm Des; 2004; 10(6):695-700. PubMed ID: 14965332
[TBL] [Abstract][Full Text] [Related]
4. The Potential Benefits of Quercetin for Brain Health: A Review of Anti-Inflammatory and Neuroprotective Mechanisms.
Chiang MC; Tsai TY; Wang CJ
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047299
[TBL] [Abstract][Full Text] [Related]
5. A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson's disease: beneficial or detrimental effects.
Alrouji M; Al-Kuraishy HM; Al-Gareeb AI; Saad HM; Batiha GE
Inflammopharmacology; 2023 Apr; 31(2):673-688. PubMed ID: 36961665
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
7. The brain as a target for inflammatory processes and neuroprotective strategies.
Skaper SD
Ann N Y Acad Sci; 2007 Dec; 1122():23-34. PubMed ID: 18077562
[TBL] [Abstract][Full Text] [Related]
8. Repositioning and development of new treatments for neurodegenerative diseases: Focus on neuroinflammation.
Arbo BD; Schimith LE; Goulart Dos Santos M; Hort MA
Eur J Pharmacol; 2022 Mar; 919():174800. PubMed ID: 35131314
[TBL] [Abstract][Full Text] [Related]
9. Fucoidan: a promising agent for brain injury and neurodegenerative disease intervention.
Wang Y; Wang Q; Han X; Ma Y; Zhang Z; Zhao L; Guan F; Ma S
Food Funct; 2021 May; 12(9):3820-3830. PubMed ID: 33861265
[TBL] [Abstract][Full Text] [Related]
10. Nitric Oxide as a Target for Phytochemicals in Anti-Neuroinflammatory Prevention Therapy.
Subedi L; Gaire BP; Parveen A; Kim SY
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946349
[TBL] [Abstract][Full Text] [Related]
11. Targeting heme oxygenase-1 for neuroprotection and neuroinflammation in neurodegenerative diseases.
Jazwa A; Cuadrado A
Curr Drug Targets; 2010 Dec; 11(12):1517-31. PubMed ID: 20704549
[TBL] [Abstract][Full Text] [Related]
12. Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents in the treatment of neurodegenerative disease.
Klegeris A; McGeer PL
Curr Alzheimer Res; 2005 Jul; 2(3):355-65. PubMed ID: 15974901
[TBL] [Abstract][Full Text] [Related]
13. Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action.
Gasparini L; Ongini E; Wenk G
J Neurochem; 2004 Nov; 91(3):521-36. PubMed ID: 15485484
[TBL] [Abstract][Full Text] [Related]
14. High bioavailability curcumin: an anti-inflammatory and neurosupportive bioactive nutrient for neurodegenerative diseases characterized by chronic neuroinflammation.
Ullah F; Liang A; Rangel A; Gyengesi E; Niedermayer G; Münch G
Arch Toxicol; 2017 Apr; 91(4):1623-1634. PubMed ID: 28204864
[TBL] [Abstract][Full Text] [Related]
15. Current Drugs and Potential Future Neuroprotective Compounds for Parkinson's Disease.
Carrera I; Cacabelos R
Curr Neuropharmacol; 2019; 17(3):295-306. PubMed ID: 30479218
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and evaluation of a series of non-steroidal anti-inflammatory drug conjugates as novel neuroinflammatory inhibitors.
Xu Z; Wu J; Zheng J; Ma H; Zhang H; Zhen X; Zheng LT; Zhang X
Int Immunopharmacol; 2015 Apr; 25(2):528-37. PubMed ID: 25765352
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration.
Chakrabarti M; Haque A; Banik NL; Nagarkatti P; Nagarkatti M; Ray SK
Brain Res Bull; 2014 Oct; 109():22-31. PubMed ID: 25245209
[TBL] [Abstract][Full Text] [Related]
18. Bioactive compounds from macroalgae in the new millennium: implications for neurodegenerative diseases.
Barbosa M; Valentão P; Andrade PB
Mar Drugs; 2014 Sep; 12(9):4934-72. PubMed ID: 25257784
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and bioactivity study of N-salicyloyl tryptamine derivatives as multifunctional agents for the treatment of neuroinflammation.
Fan X; Li J; Deng X; Lu Y; Feng Y; Ma S; Wen H; Zhao Q; Tan W; Shi T; Wang Z
Eur J Med Chem; 2020 May; 193():112217. PubMed ID: 32182488
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective Potentials of Marine Algae and Their Bioactive Metabolites: Pharmacological Insights and Therapeutic Advances.
Hannan MA; Dash R; Haque MN; Mohibbullah M; Sohag AAM; Rahman MA; Uddin MJ; Alam M; Moon IS
Mar Drugs; 2020 Jul; 18(7):. PubMed ID: 32630301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
